SecBot SecBot
Insider Cluster (3 insiders) ·Filed Nov 6, 2026

XERS

Xeris Biopharma Holdings, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed10d 11h ago
Insider cluster: 3 insiders, $0.6M total
Actionable Insight • Neutral

The sales are small relative to market cap and all under 10b5-1 plans, so they do not signal a change in insider conviction. Monitor next insider filings for any unplanned open-market sales that would break the pattern.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$15.86
T+0 close · Nov 6, 2026 · via day close
Latest settled
+5.30%
T+5 · $16.70
Vs SPY
+6.99%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $15.86entry
  2. T+1 · 7d ago −0.19%α +0.18% · $15.83
  3. T+5 · 21h ago +5.30%α +6.99% · $16.70
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three Xeris insiders sold a total of $619K in open-market sales over a week, including a sale by Kevin McCulloch the day after the company reported strong Q3 earnings and raised guidance. All sales were under 10b5-1 plans, but the aggregate value is 0.03% of market cap, well below the materiality threshold.

Key Financial Metrics

Direction
selling
Total Value
$619.0K
Insiders
3

Key Facts

  • Three insiders sold shares in open-market transactions totaling $619,000
  • All sales were conducted under 10b5-1 trading plans
  • Total sales represent approximately 0.03% of Xeris's $1.9B market cap
  • Sales occurred after Q3 2026 earnings beat and raised guidance
  • Kevin McCulloch sold $312K on Nov 5, the day after the earnings release

Financial Impact

Open-market sales of $619K, or 0.03% of market cap

insider ownership

Risk Factors

  • Insider sales are small and pre-planned, no material risk indicated

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-XERS-1794000778047

Track record

25 reports on XERS

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +45.52% at T+60 after the Aug 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Viewing Entry $15.86 Now $16.70 +5.30% settles Dec 8
  2. Nov 5, 202611d ago 144 Neutral 2/10 Entry $15.20 Now $16.70 +9.87% settles Dec 7
  3. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
  4. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
  5. Nov 4, 202612d ago 3 Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
  6. Nov 2, 202614d ago 144 Neutral 2/10 Entry $10.35 Now $16.70 +61.35% settles Dec 2
  7. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $10.17 Now $16.70 +64.21% settles Dec 1
  8. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $10.71 Now $16.70 +55.93% settles Nov 30
  9. Oct 14, 20264w ago 8-K Neutral 3/10 Entry $9.77 to $16.52 Now $16.70 +70.93% ▲ +69.09% +70.36% vs SPY
  10. Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $10.13 to $10.71 Now $16.70 +64.86% ▲ +5.73% +8.19% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 5h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026